0000950170-22-008566 | 10-Q | XBRL Viewer

Print Document View Excel Document

Derivative Financial Instruments and Hedging - Disclosure of Notional Amount of Derivatives By Hedging Designation (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 57,073	$ 50,946
Foreign currency contracts [Member] \| Derivatives designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	48,118	45,971
Foreign currency contracts [Member] \| Derivatives not designated as hedging instruments [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 8,955	$ 4,975

Net Loss Per Share

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Net Loss Per Share

14. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented:


	Three Months Ended March 31,
	2022			2021
	(in thousands, except share and per share data)
Numerator:
Net loss	$	(19,704	)	$	(7,895	)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted		97,883,814			92,679,756
Net loss per share, basic and diluted	$	(0.20	)	$	(0.09	)

The potential shares of ordinary shares that were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive are as follows:


	Three Months Ended March 31,
	2022		2021
Outstanding share options		9,346,102		12,504,417
Unvested RSUs		3,714,230		1,164,446
Share purchase rights under the ESPP		140,818		23,652
Issuable ordinary shares related to business combination		142,519		132,311
Total		13,343,669		13,824,826

Revenue Recognition - Additional Information (Detail 1)	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	12 months

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2022 (Remainder)	$ 5,549
2023	7,151
2024	6,114
2025	4,908
2026	1,823
Total operating lease payments	25,545
Less: imputed interest	(397)
Total operating lease liabilities	$ 25,148

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Summary of computation of basic and diluted net loss per share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented:


	Three Months Ended March 31,
	2022			2021
	(in thousands, except share and per share data)
Numerator:
Net loss	$	(19,704	)	$	(7,895	)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted		97,883,814			92,679,756
Net loss per share, basic and diluted	$	(0.20	)	$	(0.09	)

Summary of shares excluded from the computation of diluted net loss per share


	Three Months Ended March 31,
	2022		2021
Outstanding share options		9,346,102		12,504,417
Unvested RSUs		3,714,230		1,164,446
Share purchase rights under the ESPP		140,818		23,652
Issuable ordinary shares related to business combination		142,519		132,311
Total		13,343,669		13,824,826

Short-Term Investments - Summary of Short Term Investments (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Schedule of short term investments [Line Items]
Amortized cost	$ 369,054	$ 353,108
Gross unrealized gains	2	1
Gross unrealized losses	(983)	(265)
Estimated fair value	368,073	352,844
Bank deposits [Member]
Schedule of short term investments [Line Items]
Amortized cost	85,191	90,704
Estimated fair value	85,191	90,704
Commercial paper [Member]
Schedule of short term investments [Line Items]
Amortized cost	55,434	56,448
Gross unrealized losses	(251)	(37)
Estimated fair value	55,183	56,411
Corporate debt securities [Member]
Schedule of short term investments [Line Items]
Amortized cost	119,531	109,212
Gross unrealized gains	2	1
Gross unrealized losses	(444)	(151)
Estimated fair value	119,089	109,062
Municipal securities [Member]
Schedule of short term investments [Line Items]
Amortized cost	70,875	71,046
Gross unrealized losses	(143)	(50)
Estimated fair value	70,732	70,996
Government and agency debt [Member]
Schedule of short term investments [Line Items]
Amortized cost	38,023	25,698
Gross unrealized losses	(145)	(27)
Estimated fair value	37,878	25,671
Marketable securities [Member]
Schedule of short term investments [Line Items]
Amortized cost	283,863	262,404
Gross unrealized gains	2	1
Gross unrealized losses	(983)	(265)
Estimated fair value	$ 282,882	$ 262,140

Condensed Consolidated Balance Sheet Components

3 Months Ended

Mar. 31, 2022

Balance Sheet Related Disclosures [Abstract]

Condensed Consolidated Balance Sheet Components

7. Condensed Consolidated Balance Sheet Components

Property and Equipment, Net

Property and equipment, net consisted of the following:


	March 31, 2022			December 31, 2021
	(in thousands)
Computer and software	$	6,742		$	5,955
Furniture and office equipment		2,271			2,248
Leasehold improvements		5,432			4,893
Property and equipment, gross		14,445			13,096
Less: accumulated depreciation and amortization		(7,068	)		(6,407	)
Property and equipment, net	$	7,377		$	6,689

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:


	March 31, 2022		December 31, 2021
	(in thousands)
Accrued compensation and benefits	$	17,641	$	17,601
Accrued expenses		11,250		10,353
Accrued expenses and other current liabilities	$	28,891	$	27,954

Commitments and Contingencies

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and Contingencies

Non-cancelable Purchase Obligations

In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties mainly for hosting services, as well as software products and services. As of March 31, 2022, the Company had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:


	March 31, 2022
	(in thousands)
Year Ending December 31,
2022 (Remainder)	$	6,825
2023		23,607
2024		18,273
2025		25,917
Total	$	74,622

Indemnifications and Contingencies

The Company enters into indemnification provisions under certain agreements with other parties in the ordinary course of business. In its customer agreements, the Company has agreed to indemnify, defend and hold harmless the indemnified party for third party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic customers, the Company has agreed to indemnify, defend and hold harmless the indemnified party for non-compliance with certain additional representations and warranties made by the Company.

Grants from Israeli Innovation Authority

The Company has received in the past grants from the Israeli Innovation Authority (“IIA”) and repaid them in full. Still, as any grant recipient, the Company is subject to the provisions of the Israeli Law for the Encouragement of Research, Development and Technological Innovation in the Industry and the regulations and guidelines thereunder (the “Innovation Law”). Pursuant to the Innovation Law, there are restrictions related to transferring intellectual property outside of Israel. Such transfer requires the approval from the IIA. The approval may be subject to a maximum additional payment amount of approximately $6.0 million. In the past, the Company received an approval from the IIA to perform a limited development of IIA funded know-how outside of Israel, subject to the terms specified in the IIA approval, including that all of its core R&D activities will remain in Israel.

Legal Proceedings

In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together, have a material adverse effect on its business, financial position, results of operations, or cash flows.

Former Company sales employees (the “Former Employees”), on behalf of themselves and other non-exempt sales employees, alleged the violation of various wage and hour laws and have sought to recover unpaid wages, statutory penalties, civil penalties, liquidated damages, and attorney’s fees pursuant to certain California and federal laws. The Company denies the allegations. The Company and Former Employees have agreed to resolve the dispute amicably for approximately $2.6 million, and are currently negotiating the final settlement agreement. The settlement is subject to an arbitrator’s approval. The company has accrued the estimated settlement amount as part of sales and marketing expenses during the fourth quarter of 2021.

Leases

3 Months Ended

Mar. 31, 2022

Leases [Abstract]

Leases

9. Leases

The Company leases its office facilities under non-cancelable agreements that expire at various dates through August 2026.

Components of operating lease expense were as follows:


	Three Months Ended March 31,
	2022		2021
	(in thousands)
Operating lease cost	$	1,860	$	1,348
Short-term lease cost		88		43
Variable lease cost		92		90
Total operating lease cost	$	2,040	$	1,481

Supplementary cash flow information related to operating leases was as follows:


	Three Months Ended March 31,
	2022		2021
	(in thousands)
Cash paid for operating leases	$	1,887	$	1,163

As of March 31, 2022, the weighted-average discount rate is 0.9% and the weighted-average remaining term is 3.7 years. Maturities of the Company’s operating lease liabilities as of March 31, 2022 were as follows:


	March 31, 2022
	(in thousands)
Year Ending December 31,
2022 (Remainder)	$	5,549
2023		7,151
2024		6,114
2025		4,908
2026		1,823
Total operating lease payments		25,545
Less: imputed interest		(397	)
Total operating lease liabilities	$	25,148

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2022

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Summary of changes in AOCI

The following table summarizes the changes in AOCI by component, net of tax, during the periods presented:


	Net Unrealized Losses on Available-for-Sale Marketable Securities			Net Unrealized Gains (losses) on Derivatives Designated as Hedging Instruments			Total
	(in thousands)
Balance as of December 31, 2021	$	(264	)	$	875		$	611
Other comprehensive loss before reclassifications		(717	)		(843	)		(1,560	)
Net losses reclassified from AOCI		—			79			79
Other comprehensive loss		(717	)		(764	)		(1,481	)
Balance as of March 31, 2022	$	(981	)	$	111		$	(870	)


	Net Unrealized Losses on Available-for-Sale Marketable Securities			Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments			Total
	(in thousands)
Balance as of December 31, 2020	$	(69	)	$	441		$	372
Other comprehensive loss before reclassifications		(30	)		(393	)		(423	)
Net gains reclassified from AOCI		—			(218	)		(218	)
Other comprehensive loss		(30	)		(611	)		(641	)
Balance as of March 31, 2021	$	(99	)	$	(170	)	$	(269	)

Short-Term Investments (Tables)

3 Months Ended

Mar. 31, 2022

Investments, All Other Investments [Abstract]

Summary of short term investments

Short-term investments consisted of the following:


	March 31, 2022
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
	(in thousands)
Bank deposits	$	85,191	$	—	$	—		$	85,191
Commercial paper		55,434		—		(251	)		55,183
Corporate debt securities		119,531		2		(444	)		119,089
Municipal securities		70,875		—		(143	)		70,732
Government and agency debt		38,023		—		(145	)		37,878
Marketable securities		283,863		2		(983	)		282,882
Total short-term investments	$	369,054	$	2	$	(983	)	$	368,073


	December 31, 2021
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
	(in thousands)
Bank deposits	$	90,704	$	—	$	—		$	90,704
Commercial paper		56,448		—		(37	)		56,411
Corporate debt securities		109,212		1		(151	)		109,062
Municipal securities		71,046		—		(50	)		70,996
Government and agency debt		25,698		—		(27	)		25,671
Marketable securities		262,404		1		(265	)		262,140
Total short-term investments	$	353,108	$	1	$	(265	)	$	352,844

Commitments and Contingencies - Summary of Outstanding Non-cancelable Purchase Obligations (Detail) $ in Thousands	Mar. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022 (Remainder)	$ 6,825
2023	23,607
2024	18,273
2025	25,917
Total	$ 74,622

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 838	$ (2,357)
Unrecognized tax benefits	$ 4,400		$ 4,400

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Summary of outstanding non-cancelable purchase obligations


	March 31, 2022
	(in thousands)
Year Ending December 31,
2022 (Remainder)	$	6,825
2023		23,607
2024		18,273
2025		25,917
Total	$	74,622

Condensed Consolidated Balance Sheets (Parenthetical) - ₪ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock par value	₪ 0.01	₪ 0.01
Preferred stock authorized	50,000,000	50,000,000
Preferred stock issued	0	0
Preferred stock Outstanding	0	0
Common stock par value	₪ 0.01	₪ 0.01
Common stock Authorized	500,000,000	500,000,000
Common stock issued	98,641,858	97,312,040
Common stock Outstanding	98,641,858	97,312,040

Shareholders' Equity and Equity Incentive Plans - Summary of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 14,074	$ 11,750
Cost of revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	1,306	762
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	5,132	1,829
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	4,755	2,723
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 2,881	$ 6,436

Condensed Consolidated Balance Sheet Components - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 14,445	$ 13,096
Less: accumulated depreciation and amortization	(7,068)	(6,407)
Property and equipment, net	7,377	6,689
Computer and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,742	5,955
Furniture and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,271	2,248
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 5,432	$ 4,893

Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Balance (in shares) at Dec. 31, 2020		92,112,447
Balance at Dec. 31, 2020	$ 553,894	$ 257	$ 628,054	$ 372	$ (74,789)
Issuance of ordinary shares upon exercise of share options (in shares)		1,305,571
Issuance of ordinary shares upon exercise of share options	2,290	$ 4	2,286
Issuance of ordinary shares related to business combination (in shares)		49,823
Share-based compensation expense	11,750		11,750
Other comprehensive income (loss), net of tax	(641)			(641)
Net loss	(7,895)				(7,895)
Balance (in shares) at Mar. 31, 2021		93,467,841
Balance at Mar. 31, 2021	559,398	$ 261	642,090	(269)	(82,684)
Balance (in shares) at Dec. 31, 2021		97,312,040
Balance at Dec. 31, 2021	$ 638,581	$ 272	776,690	611	(138,992)
Issuance of ordinary shares upon exercise of share options (in shares)	1,017,669	1,017,669
Issuance of ordinary shares upon exercise of share options	$ 1,795	$ 3	1,792
Issuance of ordinary shares upon release of restricted share units (in shares)		109,416
Issuance of ordinary shares under the employee share purchase plan (shares)		154,550
Issuance of ordinary shares under the employee share purchase plan	3,253	$ 1	3,252
Issuance of ordinary shares related to business combination (in shares)		48,183
Share-based compensation expense	14,074		14,074
Other comprehensive income (loss), net of tax	(1,481)			(1,481)
Net loss	(19,704)				(19,704)
Balance (in shares) at Mar. 31, 2022		98,641,858
Balance at Mar. 31, 2022	$ 636,518	$ 276	$ 795,808	$ (870)	$ (158,696)

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Summary of table presents revenue as follows

The following table presents revenue by category:


	Three Months Ended March 31,
	2022					2021
	Amount		Percentage of Revenue			Amount		Percentage of Revenue
	(in thousands, except percentages)
Self-managed subscription	$	46,922		74	%	$	34,823		77	%
Subscription		42,295		67			31,074		69
License		4,627		7			3,749		8
SaaS		16,774		26			10,264		23
Total subscription revenue	$	63,696		100	%	$	45,087		100	%

Summary of table by region based on the shipping address of customers

The following table summarizes revenue by region based on the shipping address of customers:


	Three Months Ended March 31,
	2022					2021
	Amount		Percentage of Revenue			Amount		Percentage of Revenue
	(in thousands, except percentages)
United States	$	39,717		62	%	$	28,292		63	%
Israel		1,623		3			893		2
Rest of world		22,356		35			15,902		35
Total subscription revenue	$	63,696		100	%	$	45,087		100	%

Summary of table represents a rollforward of deferred contract acquisition costs

The following table represents a rollforward of deferred contract acquisition costs:


	Three Months Ended March 31,
	2022			2021
	(in thousands)
Beginning balance	$	14,391		$	8,196
Additions to deferred contract acquisition costs		3,571			2,362
Amortization of deferred contract acquisition costs		(1,514	)		(978	)
Ending balance	$	16,448		$	9,580
Deferred contract acquisition costs (to be recognized in next 12 months)	$	5,949		$	3,655
Deferred contract acquisition costs, noncurrent		10,499			5,925
Total deferred contract acquisition costs	$	16,448		$	9,580

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Summary of fair value by balance sheet grouping

The following table presents information about the Company’s financial instruments that are measured at fair value on a recurring basis:


	March 31, 2022
	Fair Value		Level 1		Level 2
	(in thousands)
Financial Assets:
Money market funds	$	9,585	$	9,585	$	—
Commercial paper		1,998		—		1,998
Cash equivalents		11,583		9,585		1,998
Bank deposits		85,191		—		85,191
Commercial paper		55,183		—		55,183
Corporate debt securities		119,089		—		119,089
Municipal securities		70,732		—		70,732
Government and agency debt		37,878		—		37,878
Short-term investments		368,073		—		368,073
Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets		272		—		272
Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets		134		—		134
Restricted bank deposits included in prepaid expenses and other current assets		13		—		13
Restricted bank deposits included in other assets, noncurrent		240		—		240
Total financial assets	$	380,315	$	9,585	$	370,730
Financial Liabilities:
Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities	$	161	$	—	$	161
Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities		8		—		8
Total financial liabilities	$	169	$	—	$	169


	December 31, 2021
	Fair Value		Level 1		Level 2
	(in thousands)
Financial Assets:
Money market funds	$	21,670	$	21,670	$	—
Municipal securities		175		—		175
Cash equivalents		21,845		21,670		175
Bank deposits		90,704		—		90,704
Commercial paper		56,411		—		56,411
Corporate debt securities		109,062		—		109,062
Municipal securities		70,996		—		70,996
Government and agency debt		25,671		—		25,671
Short-term investments		352,844		—		352,844
Foreign currency contracts designated as hedging instruments included in prepaid expenses and other current assets		891		—		891
Foreign currency contracts not designated as hedging instruments included in prepaid expenses and other current assets		43		—		43
Restricted bank deposits included in prepaid expenses and other current assets		13		—		13
Restricted bank deposits included in other assets, noncurrent		243		—		243
Total financial assets	$	375,879	$	21,670	$	354,209
Financial Liabilities:
Foreign currency contracts designated as hedging instruments included in accrued expenses and other current liabilities	$	16	$	—	$	16
Foreign currency contracts not designated as hedging instruments included in accrued expenses and other current liabilities		5		—		5
Total financial liabilities	$	21	$	—	$	21